Jaguar Health Inc expected to post a loss of $18.50 a share - Earnings Preview

Jaguar Health

28/03/2025 11:08

Jaguar Health Inc JAGX.OQ JAGX.O is expected to show a rise in quarterly revenue when it reports  results on March 31 (estimated) for the period ending December 31 2024

The San Francisco California-based  company is expected to report a 36.1% increase in revenue to $3.13 million from $2.3 million a year ago, according to the estimate from one analyst, based on LSEG data.

​LSEG's mean analyst estimate for Jaguar Health Inc is for a loss of $18.50 per share.

The one available analyst rating on the shares is "strong buy".

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Jaguar Health Inc is $150.00​, above​ its last closing price of $5.38. ​​​

This summary was machine generated March 28 at 11:08 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)